Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
170M
-
Number of holders
-
117
-
Total 13F shares, excl. options
-
37.7M
-
Shares change
-
-490K
-
Total reported value, excl. options
-
$321M
-
Value change
-
-$4.3M
-
Put/Call ratio
-
0.08
-
Number of buys
-
57
-
Number of sells
-
-59
-
Price
-
$8.52
Significant Holders of Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) as of Q4 2021
146 filings reported holding IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share as of Q4 2021.
Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) has 117 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37.7M shares
of 170M outstanding shares and own 22.18% of the company stock.
Largest 10 shareholders include EVENTIDE ASSET MANAGEMENT, LLC (4.95M shares), Deep Track Capital, LP (4.78M shares), VANGUARD GROUP INC (3.83M shares), BlackRock Inc. (3.33M shares), Alpine Global Management, LLC (3.01M shares), STATE STREET CORP (2.78M shares), EcoR1 Capital, LLC (1.14M shares), Point72 Asset Management, L.P. (901K shares), TWO SIGMA INVESTMENTS, LP (854K shares), and GEODE CAPITAL MANAGEMENT, LLC (820K shares).
This table shows the top 117 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.